Feed / BIOA

BioAge Labs, Inc.

BIOA

Healthcare · 10.73 -50.8% today

Participation confirmed · construction unavailableMarket checked 19 Aug, 15:55 GMT-4

Jodie situation report

BioAge Labs, Inc.'s move is being confirmed by its market group.

No new filing conclusion is available. 23 of 24 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.

Company-50.8% todayVolume comparison unavailable
Market group23 of 24 activeRare Disease Biotech · active
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 16 of 24 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as XNCR begins moving with the group.

Invalidation: The live read weakens if participation falls to 8 of 24 members or fewer.

Watch this read

Who this business touches

The relationships behind BIOA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

NVSNovartis AGpartnerMay 8, 2026

We are also advancing earlier stage platform-derived programs in collaboration with Eli Lilly and Company (Lilly), and have an ongoing target discovery collaboration with Novartis Pharma AG (Novartis).

LLYEli Lilly and CompanypartnerMay 8, 2026

We are also advancing earlier stage platform-derived programs in collaboration with Eli Lilly and Company (Lilly), and have an ongoing target discovery collaboration with Novartis Pharma AG (Novartis).

AZNAstraZeneca PLCpartnerMar 24, 2026

However, we are aware of NLRP3 inhibitor pipeline programs including those from Ventyx Biosciences (pending acquisition by Eli Lilly), NodThera, Roche, Merck, Novo Nordisk, AstraZeneca, Neumora, Ventus, Tenvie, Insilico, Brenig, and Zydus.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

BIOA is currently a Participant in the organic co-movement group Rare Disease Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.